2[2]Duvic M,Asano AT,Kerenyi M,et al.Tazarotene induces epidermal cell differentiation in the mouse tail test used as an animal model for psoriasis[J].Skin Pharmacol Appl Skin Physiol,2000,13(5):285-291.
3[3]Lavker RM,Leyden JJ.An ultrastruchural study of the effects of topical tretinoin on microcomedones[J].Clin The,1994,14:773-780.
4[4]Challker Dk, Lesher JL Jr, Smith JG Jr,et al.Efficacy of topical isotretinoin 0.05% gel in acne vulgaris:results of a multicenter,double-blind investgation[J]. Am Acad Dermatol,1987,7:251-254.
5[5]Tang-Liu DD,Matsumoto RM,Usansky JI.Clinical Pharmacokinetics and drug metabolism of tazarotene:a novel topical treatment for acne and psoriasis[J].Clin Pharmacokinet,1999,37:273-287.
6[6]Marks R.Pharmacokinetics and safty review of tazarotene[J].Am Aced Dermatol,1998,39:S134-138.
7Leyden JJ, Tanghetti EA, Miller B,et al.Once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.1% microsponge gel for the treatment of facial acne vulgaris:double-blind randomized trial[J].Cutis,2002,69(2):12-19.
8Webster GF,Guenthor L,Poulin YP,et al.A multicenter,double-blind,randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the tazarotene of facial acne vulgaris[J].Cutis,2002,69(2):4-11.
9Gerald D,Weinstein MD,John YM,et al.Tazarotene cream in the treatment of psoriasis:two multicenter double-blind,randomized,vehicle-controlled studies of the safety and efficacy of tazarotene cream 0.05% and 0.1% applied once daily for 12 weeks[J].J Am Aca
10Bershad S,Kranjac SG,Parente JE,et al.Successful treatment of acne vulgaris using a new method:results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel[J].Arch Dermatol,2002,138(4):481-489.
